[en] X-linked adrenoleukodystrophy (X-ALD) is a peroxisomal disorder caused by mutations in the ABCD1 (ALD) gene. The ABCD2 gene, its closest homolog, has been shown to compensate for ABCD1 deficiency when overexpressed. We previously demonstrated that the ABCD2 promoter contains a functional thyroid hormone response element. Thyroid hormone (T3) through its receptor TRbeta can induce hepatic Abcd2 expression in rodents and transiently normalize the VLCFA level in fibroblasts of Abcd1 null mice. In a therapeutic perspective, the use of selective agonists of TRbeta should present the advantage to be devoid of side effects, at least concerning the cardiotoxicity associated to TRalpha activation. In this study, we compared the effects of T3 with those of two thyromimetics (GC-1 and CGS 23425) specific of TRbeta. Using a gene reporter assay, we demonstrated that the rat Abcd2 promoter responds to the thyromimetics in a dose-dependent way similar to what is observed with T3. We then investigated the effects of 2-, 4- and 10-day treatments on the expression of ABCD2 and its paralogs ABCD3 and ABCD4 in human cell lines by RT-qPCR. Both thyromimetics trigger up-regulation of ABCD2-4 genes in HepG2 cells and X-ALD fibroblasts. Interestingly, in X-ALD fibroblasts, while T3 is associated with a transient induction of ABCD2 and ABCD3, the treatments with thyromimetics allow the induction to be maintained until 10 days. Further in vivo experiments in Abcd1 null mice with these thyromimetics should confirm the therapeutic potentialities of these molecules.
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Genin, Emmanuelle ; INSERM U866, Université de Bourgogne - France > Laboratoire de Biochimie Métabolique et Nutritionnelle
Gondcaille, Catherine; INSERM U866, Université de Bourgogne - France > Laboratoire de Biochimie Métabolique et Nutritionnelle
Trompier, Doriane; INSERM U866, Université de Bourgogne - France > Laboratoire de Biochimie Métabolique et Nutritionnelle
Savary, Stéphane; INSERM U866, Université de Bourgogne - France > Laboratoire de Biochimie Métabolique et Nutritionnelle
Language :
English
Title :
Induction of the adrenoleukodystrophy-related gene (ABCD2) by thyromimetics
Publication date :
August 2009
Journal title :
Journal of Steroid Biochemistry and Molecular Biology
Moser H.W., Smith K.D., Watkins P.A., Powers J., and Moser A.B. X-linked adrenoleukodystrophy. In: Scriver R., Beaudet A.L., Sly W.S., and Valle D. (Eds). The Metabolic & Molecular Bases of inherited Disease. eighth (2001), McGraw-Hill Book Co., New York 3257-3301
Berger J., and Gartner J. X-linked adrenoleukodystrophy: clinical, biochemical and pathogenetic aspects. Biochim. Biophys. Acta 1763 12 (2006) 1721-1732
Lombard-Platet G., Savary S., Sarde C.O., Mandel J.L., and Chimini G. A close relative of the adrenoleukodystrophy (ALD) gene codes for a peroxisomal protein with a specific expression pattern. Proc. Natl. Acad. Sci. U.S.A. 93 3 (1996) 1265-1269
Kamijo K., Taketani S., Yokota S., Osumi T., and Hashimoto T. The 70-kDa peroxisomal membrane protein is a member of the Mdr (P-glycoprotein)-related ATP-binding protein superfamily. J. Biol. Chem. 265 8 (1990) 4534-4540
Holzinger A., Kammerer S., and Roscher A.A. Primary structure of human PMP69, a putative peroxisomal ABC-transporter. Biochem. Biophys. Res. Commun. 237 1 (1997) 152-157
Shani N., Jimenez-Sanchez G., Steel G., Dean M., and Valle D. Identification of a fourth half ABC transporter in the human peroxisomal membrane. Hum. Mol. Genet. 6 11 (1997) 1925-1931
Kashiwayama Y., Seki M., Yasui A., Murasaki Y., Morita M., Yamashita Y., Sakaguchi M., Tanaka Y., and Imanaka T. 70-kDa peroxisomal membrane protein related protein (P70R/ABCD4) localizes to endoplasmic reticulum not peroxisomes, and NH2-terminal hydrophobic property determines the subcellular localization of ABC subfamily D proteins. Exp. Cell. Res. 315 2 (2009) 190-205
Braiterman L.T., Zheng S., Watkins P.A., Geraghty M.T., Johnson G., McGuinness M.C., Moser A.B., and Smith K.D. Suppression of peroxisomal membrane protein defects by peroxisomal ATP binding cassette (ABC) proteins. Hum. Mol. Genet. 7 2 (1998) 239-247
Flavigny E., Sanhaj A., Aubourg P., and Cartier N. Retroviral-mediated adrenoleukodystrophy-related gene transfer corrects very long chain fatty acid metabolism in adrenoleukodystrophy fibroblasts: implications for therapy. FEBS Lett. 448 2-3 (1999) 261-264
Netik A., Forss-Petter S., Holzinger A., Molzer B., Unterrainer G., and Berger J. Adrenoleukodystrophy-related protein can compensate functionally for adrenoleukodystrophy protein deficiency (X-ALD): implications for therapy. Hum. Mol. Genet. 8 5 (1999) 907-913
Pujol A., Ferrer I., Camps C., Metzger E., Hindelang C., Callizot N., Ruiz M., Pampols T., Giros M., and Mandel J.L. Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy. Hum. Mol. Genet. 13 23 (2004) 2997-3006
Albet S., Causeret C., Bentejac M., Mandel J.L., Aubourg P., and Bugaut M. Fenofibrate differently alters expression of genes encoding ATP-binding transporter proteins of the peroxisomal membrane. FEBS Lett. 405 3 (1997) 394-397
Kemp S., Wei H.M., Lu J.F., Braiterman L.T., McGuinness M.C., Moser A.B., Watkins P.A., and Smith K.D. Gene redundancy and pharmacological gene therapy: implications for X-linked adrenoleukodystrophy. Nat. Med. 4 11 (1998) 1261-1268
Fourcade S., Savary S., Albet S., Gauthe D., Gondcaille C., Pineau T., Bellenger J., Bentejac M., Holzinger A., Berger J., and Bugaut M. Fibrate induction of the adrenoleukodystrophy-related gene (ABCD2): promoter analysis and role of the peroxisome proliferator-activated receptor PPARalpha. Eur. J. Biochem. 268 12 (2001) 3490-3500
Bugaut M., Fourcade S., Gondcaille C., Gueugnon F., Depreter M., Roels F., Netik A., Berger J., Martin P., Pineau T., Cadepond F., El Etr M., and Savary S. Pharmacological induction of redundant genes for a therapy of X-ALD: phenylbutyrate and other compounds. Adv. Exp. Med. Biol. 544 (2003) 281-291
Gondcaille C., Depreter M., Fourcade S., Lecca M.R., Leclercq S., Martin P.G., Pineau T., Cadepond F., Eletr M., Bertrand N., Beley A., Duclos S., De Craemer D., Roels F., Savary S., and Bugaut M. Phenylbutyrate up-regulates the adrenoleukodystrophy-related gene as a nonclassical peroxisome proliferator. J. Cell Biol. 169 (2005) 93-104
Fourcade S., Savary S., Gondcaille C., Berger J., Netik A., Cadepond F., El Etr M., Molzer B., and Bugaut M. Thyroid hormone induction of the adrenoleukodystrophy-related gene (ABCD2). Mol. Pharmacol. 63 6 (2003) 1296-1303
Gueugnon F., Gondcaille C., Leclercq S., Bellenger J., Bellenger S., Narce M., Pineau T., Bonnetain F., and Savary S. Dehydroepiandrosterone up-regulates the Adrenoleukodystrophy-related gene (ABCD2) independently of PPARalpha in rodents. Biochimie 89 11 (2007) 1312-1321
Just W.W., and Hartl F.U. Rat liver peroxisomes, II. Stimulation of peroxisomal fatty-acid beta-oxidation by thyroid hormones. Hoppe Seylers Z. Physiol. Chem. 364 11 (1983) 1541-1547
Hartl F.U., and Just W.W. Integral membrane polypeptides of rat liver peroxisomes: topology and response to different metabolic states. Arch. Biochem. Biophys. 255 1 (1987) 109-119
Yen P.M. Physiological and molecular basis of thyroid hormone action. Physiol. Rev. 81 3 (2001) 1097-1142
Yen P.M., Ando S., Feng X., Liu Y., Maruvada P., and Xia X. Thyroid hormone action at the cellular, genomic and target gene levels. Mol. Cell. Endocrinol. 246 1-2 (2006) 121-127
Zhang J., and Lazar M.A. The mechanism of action of thyroid hormones. Annu. Rev. Physiol. 62 (2000) 439-466
Bianco A.C., and Kim B.W. Deiodinases: implications of the local control of thyroid hormone action. J. Clin. Invest. 116 10 (2006) 2571-2579
Scanlan T.S., Yoshihara H.A., Nguyen N.H., and Chiellini G. Selective thyromimetics: tissue-selective thyroid hormone analogs. Curr. Opin. Drug Discov. Dev. 4 5 (2001) 614-622
Malm J., Grover G.J., and Farnegardh M. Recent advances in the development of agonists selective for beta1-type thyroid hormone receptor. Mini Rev. Med. Chem. 7 1 (2007) 79-86
Chiellini G., Apriletti J.W., Yoshihara H.A., Baxter J.D., Ribeiro R.C., and Scanlan T.S. A high-affinity subtype-selective agonist ligand for the thyroid hormone receptor. Chem. Biol. 5 6 (1998) 299-306
Taylor A.H., Stephan Z.F., Steele R.E., and Wong N.C. Beneficial effects of a novel thyromimetic on lipoprotein metabolism. Mol. Pharmacol. 52 3 (1997) 542-547
Baxter J.D., Webb P., Grover G., and Scanlan T.S. Selective activation of thyroid hormone signaling pathways by GC-1: a new approach to controlling cholesterol and body weight. Trends Endocrinol. Metab. 15 4 (2004) 154-157
Johansson L., Rudling M., Scanlan T.S., Lundasen T., Webb P., Baxter J., Angelin B., and Parini P. Selective thyroid receptor modulation by GC-1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid mice. Proc. Natl. Acad. Sci. U.S.A. 102 29 (2005) 10297-10302
Morte B., Manzano J., Scanlan T., Vennstrom B., and Bernal J. Deletion of the thyroid hormone receptor alpha 1 prevents the structural alterations of the cerebellum induced by hypothyroidism. Proc. Natl. Acad. Sci. U.S.A. 99 6 (2002) 3985-3989
Perra A., Simbula G., Simbula M., Pibiri M., Kowalik M.A., Sulas P., Cocco M.T., Ledda-Columbano G.M., and Columbano A. Thyroid hormone (T3) and TRbeta agonist GC-1 inhibit/reverse nonalcoholic fatty liver in rats. FASEB J. 22 8 (2008) 2981-2989
Weinhofer I., Kunze M., Rampler H., Forss-Petter S., Samarut J., Plateroti M., and Berger J. Distinct modulatory roles for thyroid hormone receptors TRalpha and TRbeta in SREBP1-activated ABCD2 expression. Eur. J. Cell. Biol. 87 12 (2008) 933-945
Timmer D.C., Bakker O., and Wiersinga W.M. Triiodothyronine affects the alternative splicing of thyroid hormone receptor alpha mRNA. J. Endocrinol. 179 2 (2003) 217-225
Suzuki S., Miyamoto T., Opsahl A., Sakurai A., and DeGroot L.J. Two thyroid hormone response elements are present in the promoter of human thyroid hormone receptor beta 1. Mol. Endocrinol. 8 3 (1994) 305-314
Kester M.H., Kuiper G.G., Versteeg R., and Visser T.J. Regulation of type III iodothyronine deiodinase expression in human cell lines. Endocrinology 147 12 (2006) 5845-5854
St Germain D.L., and Galton V.A. The deiodinase family of selenoproteins. Thyroid 7 4 (1997) 655-668
Asheuer M., Bieche I., Laurendeau I., Moser A., Hainque B., Vidaud M., and Aubourg P. Decreased expression of ABCD4 and BG1 genes early in the pathogenesis of X-linked adrenoleukodystrophy. Hum. Mol. Genet. 14 10 (2005) 1293-1303
Wada Y., Matsubara S., Dufresne J., Hargrove G.M., Stephan Z.F., Steele R.E., and Wong N.C. Effects of a thyromimetic on apolipoprotein B-100 in rats. J. Mol. Endocrinol. 25 3 (2000) 299-308
Bengoechea-Alonso M.T., and Ericsson J. SREBP in signal transduction: cholesterol metabolism and beyond. Curr. Opin. Cell Biol. 19 2 (2007) 215-222
Weinhofer I., Kunze M., Rampler H., Bookout A.L., Forss-Petter S., and Berger J. Liver X receptor alpha interferes with SREBP1c-mediated Abcd2 expression. Novel cross-talk in gene regulation. J. Biol. Chem. 280 50 (2005) 41243-41251
Weinhofer I., Forss-Petter S., Zigman M., and Berger J. Cholesterol regulates ABCD2 expression: implications for the therapy of X-linked adrenoleukodystrophy. Hum. Mol. Genet. 11 22 (2002) 2701-2708
Janssen A., Gressens P., Grabenbauer M., Baumgart E., Schad A., Vanhorebeek I., Brouwers A., Declercq P.E., Fahimi D., Evrard P., Schoonjans L., Collen D., Carmeliet P., Mannaerts G., Van Veldhoven P., and Baes M. Neuronal migration depends on intact peroxisomal function in brain and in extraneuronal tissues. J. Neurosci. 23 30 (2003) 9732-9741
Baas D., Puymirat J., and Sarlieve L.L. Posttranscriptional regulation of oligodendroglial thyroid hormone (T3) receptor beta 1 by T3. Int. J. Dev. Neurosci. 16 6 (1998) 461-467
Sarlieve L.L., Rodriguez-Pena A., and Langley K. Expression of thyroid hormone receptor isoforms in the oligodendrocyte lineage. Neurochem. Res. 29 5 (2004) 903-922
Baas D., Legrand C., Samarut J., and Flamant F. Persistence of oligodendrocyte precursor cells and altered myelination in optic nerve associated to retina degeneration in mice devoid of all thyroid hormone receptors. Proc. Natl. Acad. Sci. U.S.A. 99 5 (2002) 2907-2911
Jones S.A., Jolson D.M., Cuta K.K., Mariash C.N., and Anderson G.W. Triiodothyronine is a survival factor for developing oligodendrocytes. Mol. Cell. Endocrinol. 199 1-2 (2003) 49-60
